Clinical Pharmacokinetics of Cefotiam

[1]  J. Barbare,et al.  [Course of the diffusion of cefotiam in infected ascitic fluid]. , 1987, Pathologie-biologie.

[2]  J. Arnaud,et al.  Biliary elimination of cefotiam, an experimental and clinical study. , 1986, Chemotherapy.

[3]  M. Charton,et al.  [Passage of cefotiam into prostatic tissue]. , 1985, Pathologie-biologie.

[4]  Y. Chotard,et al.  [Diffusion of cefotiam into ascitic fluid]. , 1985, Pathologie-biologie.

[5]  M. Rouan,et al.  Pharmacokinetics of cefotiam in humans , 1985, Antimicrobial Agents and Chemotherapy.

[6]  G. Vallancien,et al.  Passage du céfotiam dans le tissu prostatique. , 1985 .

[7]  U. Binswanger,et al.  Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients. , 1984, The Journal of antimicrobial chemotherapy.

[8]  J. Ortonne,et al.  [Evaluation of the extravascular distribution of cefotiam (SCE 963) by the skin blister technic]. , 1984, Pathologie-biologie.

[9]  Y. Matsuura,et al.  [Experimental and clinical studies of cefotiam in thoracic surgery]. , 1983, The Japanese journal of antibiotics.

[10]  F. Daschner,et al.  [Concentrations of cefotiam in serum, heart valves, muscle and adipose tissue during heart surgery]. , 1983, Arzneimittel-Forschung.

[11]  F. Daschner,et al.  Pharmacokinetics of cefotiam in normal humans , 1982, Antimicrobial Agents and Chemotherapy.

[12]  M. Taniura,et al.  Cefotiam concentrations in bile and in the wall of the gallbladder in patients with biliary disease. , 1982, The Journal of antimicrobial chemotherapy.

[13]  R. Wise.  PENICILLINS AND CEPHALOSPORINS: ANTIMICROBIAL AND PHARMACOLOGICAL PROPERTIES , 1982, The Lancet.

[14]  S. Kikuchi,et al.  [Concentration of cefotiam in the human bone marrow fluid and bone tissue (author's transl)]. , 1982, The Japanese journal of antibiotics.

[15]  K. Itakura,et al.  High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine. , 1982, Chemical & pharmaceutical bulletin.

[16]  E. Bergogne-Bérézin,et al.  Study of the diffusion of cefotiam in the bronchial secretions. , 1982, Chemotherapy.

[17]  R. Wise,et al.  Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison. , 1981, The Journal of antimicrobial chemotherapy.

[18]  A. Morimoto,et al.  SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 7β-[2-(2-AMINOTHIAZOL-4-YL)ACETAMIDO]CEPHALOSPORIN DERIVATIVES , 1981 .

[19]  T. Kaneko,et al.  Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]-cephalosporin derivatives. I. Synthesis and antibacterial activity of 7 beta-[2-alkyl- and 2-hydroxy-2-(2-aminothiazol-4-yl)-acetamido]cephalosporins. , 1980, The Journal of antibiotics.

[20]  C. O'callaghan.  Description and classification of the newer cephalosporins and their relationships with the established compounds. , 1979, The Journal of antimicrobial chemotherapy.

[21]  T. Vree,et al.  Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency. , 1979, The Journal of antimicrobial chemotherapy.

[22]  M. Yoneda,et al.  SCE-963, a New Potent Cephalosporin with High Affinity for Penicillin-Binding Proteins 1 and 3 of Escherichia coli , 1979, Antimicrobial Agents and Chemotherapy.

[23]  H. Akimoto,et al.  A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships. , 1978, The Journal of antibiotics.

[24]  Y. Kanai,et al.  Metabolic fate of SCE-963, a new broad-spectrum cephalosporin, after parenteral administration in rats and dogs. , 1978, The Journal of antibiotics.